On the heels of its successful collaboration with Alphabet's Verily Life Sciences, Johnson & Johnson (NYSE:JNJ) has agreed to acquire the remaining stake in robotics and data science venture Verb Surgical for an undisclosed sum. The transaction should close in H1 2020.
Verb was a joint venture formed between J&J unit Ethicon and Google Life Sciences in late 2015.
